# A Bidirectional Cohort Study of COMMD10 Expression in Tumor Tissues for Predicting Radiosensitivity

> **NCT06165224** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 400 (estimated)

## Conditions studied

- Biomarker
- Radiosensitivity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06165224
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06165224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06165224, "A Bidirectional Cohort Study of COMMD10 Expression in Tumor Tissues for Predicting Radiosensitivity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06165224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*